Court Decides Whether Clinicians Have Legal Immunity Due to COVID-19 Response
This month’s case is an example of what behavior the courts might consider protected, and what might not be.
COVID19
Dapagliflozin Well Tolerated in COVID-19 Patients, Regardless of eGFR
Effects of dapagliflozin on primary and secondary outcomes consistent for those with eGFR <60 and ≥60 mL/min per 1.73 m2
FDA Panel Will Meet to Discuss Multiple COVID-19 Vaccine EUA Requests
The panel intends to discuss the SARS-CoV-2 strain composition of COVID-19 vaccines, in addition to authorization for use in younger children.
Moderna Submits Request for Emergency Use of COVID-19 Vaccine for Young Children
The KidCOVE study included children 6 months to less than 6 years of age who received either two 25mcg doses of mRNA-1273 or placebo, separated by 28 days.
Vaccination Cuts Severe COVID-19 Risk in Heart Transplant Patients
COVID-19 vaccination is not associated with heart transplant-specific adverse events
MPR Weekly Dose Podcast Episode 114
USPSTF recommendations on aspirin use to prevent cardiovascular disease; Veklury indication expanded; Five Accupril Lots recalled; Legal action on counterfeit HIV medication; And the White House releases a plan to tackle the overdose epidemic.
Natural COVID-19 Immunity Produces Protection Similar to Vaccines
Similar natural protection seen against mild and severe disease
White House Moves to Make COVID-19 Antiviral Pills More Widely Available
Many Americans have said they cannot find a doctor to prescribe Paxlovid or a pharmacy that has it
Risk for Guillain-Barré Syndrome Up After Ad.26.COV2.S Vaccination
Adjusted rate ratio of 20.56 found in head-to-head comparison of Ad.26.COV2.S with mRNA COVID-19 vaccines
Veklury Approval Expanded to Include COVID-19 Treatment in Younger Children
The approval was supported by data from a phase 2/3 CARAVAN study.
